Association between outcomes registry for better informed treatment risk score components and major bleeding
| Variable . | Hazard ratioa . | 95% CI HR . | Chi-square-value . | Points . |
|---|---|---|---|---|
| Older age | 1.38 | 1.17–1.61 | 15 | 1 |
| Reduced haemoglobin/Hct/anaemia | 2.07 | 1.74–2.47 | 66 | 2 |
| Bleeding history | 1.73 | 1.34–2.23 | 18 | 2 |
| Insufficient kidney function | 1.44 | 1.21–1.72 | 17 | 1 |
| Treatment with antiplatelets | 1.51 | 1.30–1.75 | 30 | 1 |
| Variable . | Hazard ratioa . | 95% CI HR . | Chi-square-value . | Points . |
|---|---|---|---|---|
| Older age | 1.38 | 1.17–1.61 | 15 | 1 |
| Reduced haemoglobin/Hct/anaemia | 2.07 | 1.74–2.47 | 66 | 2 |
| Bleeding history | 1.73 | 1.34–2.23 | 18 | 2 |
| Insufficient kidney function | 1.44 | 1.21–1.72 | 17 | 1 |
| Treatment with antiplatelets | 1.51 | 1.30–1.75 | 30 | 1 |
aOutcomes registry for better informed treatment bleeding risk score components (point value) = older than 74 (1), reduced haemoglobin/anaemia (2), bleeding history (2), insufficient kidney function (<60 mL/min/1.73 m2) (1), treatment with antiplatelet (1). Abnormal haemoglobin (<13 mg/dL for males and <12 mg/dL for females) or haematocrit (<40% for males and <36% for females).
Association between outcomes registry for better informed treatment risk score components and major bleeding
| Variable . | Hazard ratioa . | 95% CI HR . | Chi-square-value . | Points . |
|---|---|---|---|---|
| Older age | 1.38 | 1.17–1.61 | 15 | 1 |
| Reduced haemoglobin/Hct/anaemia | 2.07 | 1.74–2.47 | 66 | 2 |
| Bleeding history | 1.73 | 1.34–2.23 | 18 | 2 |
| Insufficient kidney function | 1.44 | 1.21–1.72 | 17 | 1 |
| Treatment with antiplatelets | 1.51 | 1.30–1.75 | 30 | 1 |
| Variable . | Hazard ratioa . | 95% CI HR . | Chi-square-value . | Points . |
|---|---|---|---|---|
| Older age | 1.38 | 1.17–1.61 | 15 | 1 |
| Reduced haemoglobin/Hct/anaemia | 2.07 | 1.74–2.47 | 66 | 2 |
| Bleeding history | 1.73 | 1.34–2.23 | 18 | 2 |
| Insufficient kidney function | 1.44 | 1.21–1.72 | 17 | 1 |
| Treatment with antiplatelets | 1.51 | 1.30–1.75 | 30 | 1 |
aOutcomes registry for better informed treatment bleeding risk score components (point value) = older than 74 (1), reduced haemoglobin/anaemia (2), bleeding history (2), insufficient kidney function (<60 mL/min/1.73 m2) (1), treatment with antiplatelet (1). Abnormal haemoglobin (<13 mg/dL for males and <12 mg/dL for females) or haematocrit (<40% for males and <36% for females).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
